Zika Virus, Microcephaly and its Possible Global Spread by Badshah, Syed Lal et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books






Zika Virus, Microcephaly and its Possible Global Spread
Syed Lal Badshah, Yahia Nasser Mabkhot,
Nasir Ahmad, Shazia Syed and Abdul Naeem
Additional information is available at the end of the chapter
http://dx.doi.org/10.5772/intechopen.72507
© 2016 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons 
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use, distribution, 
and reproduction in any medium, provided the original work is properly cited. 
Syed Lal Badshah, Yahia Nasser Mabkhot, Nasir Ahmad, 
Shazia Syed and Abdul Naeem
Additional information is available at the end of the chapter
Abstract
Zika virus is an arbovirus that is spreading at an alarming state in the American continents 
and now in Asian countries. The Aedes mosquitoes are the vectors for the spread of this 
virus beside other ways of transmission. Currently, there are no vaccines or drugs available 
for its treatment. The Zika virus–related microcephaly cases are reported in fetuses of preg-
nant women who got this viral infection. However, the exact mechanism of Zika virus and 
microcephaly is still not established. Here we review Zika virus epidemiology, its unusual 
relationship with microcephaly in fetuses and current scientific research progress on it.
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1. Introduction and background
Zika virus (ZIKV) of the family Flaviviridae was on the list of neglected diseases, and like all 
neglected diseases, it is now an epidemic causing microcephaly in new-born and Guillain-
Barré syndrome in adults [1]. The Aedes aegypti mosquitoes are the main vectors for it beside 
other reported species like Aedes hensilli [2]. Historically, it was identified back in 1947, and 
recently, Chang et al. have thoroughly discussed its full history [3] and several authors have 
reviewed the literature [4–9], but still there is a need for updated information. In the past 70 
years, different strains of Zika virus have been isolated from time to time in different parts of 
Africa [10–15]. It is generally believed that the current progress in human travel technology 
and its frequent use by people and the spread of Aedes due to its invasive nature cause the 
global spread of Zika virus [6]. Zika virus infection was also reported in a few returning trav-
elers in the Netherland and Switzerland, so its possible spread to the Europe is also difficult 
to avoid [16–18]. It was recently reported that another vector mosquito called Aedes albopictus 
has the capacity to spread Zika virus in North America and Europe [19].
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The threat of Zika virus to the United States population was not given importance initially, 
but several reports from Puerto Rico, Texas, and other parts alarm bells in the scientific com-
munity and a wake-up call to National Institute of Health [20, 21]. Zika virus is now on the 
door step of Asia with cases reported from Manila (Philippines), and parts of Singapore, 
Thailand, India, etc., which have favorable environmental conditions for Aedes mosquitos, 
and in the past, minor outbreaks were also recorded [14, 22–24]. This is an alarming situa-
tion and there is no preparation on the emergency basis. In the past, several cases of Zika 
virus were reported in Asian countries like Cambodia [25] and Senegal in Africa [26, 27], 
but it was not that widespread. Before 2007, few cases were reported at different places in 
different times, but it is suggested that increase in mosquito breeding and environmental 
changes due to human activities may cause mutation in the RNA genome of Zika virus and it 
becomes more adaptable to the mosquitos [28, 29]. In 2014–2015, Zika virus infection spread 
in South and Central America and Caribbean regions and is now spreading to other parts of 
the world [20, 30]. The spread of Zika virus in northeastern parts of Brazil occurred in the 
beginning of 2015 when it was observed that some patients had mild fever, rash, conjuncti-
vitis and arthralgia and their tests were negative for dengue virus [31]. Later on, the reverse 
transcription-polymerase chain reaction from the sera showed the presence of Zika virus and 
its classification showed that it belonged to the Asian group [31]. The human skin fibroblasts 
cells are permissive to Zika virus entry. The viral replication in infected cells causes activation 
of an antiviral innate immune response with the production of type I interferons [32].
2. Transmission
The common possible ways of spreading beside the mosquito bites and transplacental trans-
mission are blood transfusion, transplantation of organs, sexual activities, breastfeeding [33], 
respiratory along with sweat and tear droplets and animal bite [28, 34]. In North America 
and European countries, the spread through sexual contacts are more as these regions are 
not favorable for Aedes mosquitos [35]. In such areas, blood and semen donations should be 
properly checked for the presence of Zika virus, and further, people coming from affected 
areas should take care when they donate blood and semen in unaffected areas [36].
3. Relation between Zika virus and microcephaly
Microcephaly is one of the associated medical effects of Zika virus infection in mothers with 
their new born babies [36–40]. In the past, cases of Zika virus with microcephaly were not that 
common, but in Brazil, it was observed that the rate of microcephaly is twenty times more, 
which is quite alarming and new cases are still emerging [41]. Zika virus has the capacity to 
cross the placental barrier and infect the fetus [42, 43]. The infected mothers of these babies 
have rashes in the first and second trimesters [44]. Beside microcephaly, brain calcifications, 
cataracts and intraocular calcifications of eyes in fetuses are also reported [45]. In other cases, 
agyria, hydrocephalus and associated cortical displacement and mild focal inflammation are 
also present [46–48]. Similarly in another case in addition to the above-mentioned symptoms, 
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ultrasound of the infected fetus showed damaged lesions of posterior fossa and ascites along 
with subcutaneous edema [49]. Recent studies also suggested that the brain tissue and cells are 
favorable places for Zika virus growth as it targets the brain tissues in the neonate very easily 
[50, 51]. Zika virus decreases the viability and growth of neurospheres and brain organoids, and 
in that way, it targets the brain to cause microcephaly [52, 53]. Bullerdiek et al. hypothesized 
that the virus proteins affect the mitotic spindle proteins and their apparatus and this could be 
the possible way through which Zika virus causes teratogenic effects like microcephaly [54].
There are also ambiguities about the role of Zika virus and microcephaly, as in the past micro-
cephaly was not linked with Zika virus infection, and the cases of microcephaly were very low 
and it is possible that other factors may be involved in it [55, 56]. Evans et al. suggested that the 
insecticide pyriproxyfen that is used for the control of mosquito populations in drinking water is 
the possible agent for microcephaly in Brazil [57]. The insecticide pyriproxyfen has shown to act 
as juvenile hormone and has cross-reactivity with most of the fat soluble molecules like retinoic 
acid (a  metabolite of vitamin A) and a ligand for RXR receptor [57]. The RXR receptor is a type 
of nuclear receptor and this cross-reactivity of two agents results into abnormal activity of RXR 
receptors with the ultimate abnormality of microcephaly [57]. However, experiments on zebra 
fish models showed that pyriproxyfen did not cause any deformities in the central nervous sys-
tem [58]. To counter such ambiguities, different groups are studying the effect of Zika virus on 
mouse models, and in one of the recent reports, the researchers showed that when a mouse is 
infected with a Brazilian Zika virus strain, it causes intrauterine growth restriction and signs of 
microcephaly were also observed [59]. They also showed that Zika virus attacks the human corti-
cal progenitor cells and destroys them, and further the viral infection also damages the human 
brain organoids with a decrease in proliferative zones and damages the cortical layers [59]. In 
different brain and neural cells infected with Zika virus, it has been observed that the viruses halt 
the process of mitoses and damage the centrosome and the structural organization of the divid-
ing cell with ultimate result of cell death [60]. It has been observed that a single point mutation of 
serine to asparagine (S139 N) in the ZIKV polyprotein resulted in high virulence ability in human 
progenitor cells [61]. This mutation occurred before the 2013 French Polynesia and was main-
tained during the later spread of ZIKV in the Brazil and its neighbors [61]. ZIKV has the capacity 
to infect the placental barrier cells and thus damage the fetus [62]. ZIKV has the sole capacity to 
interact with anexelekto, meaning uncontrolled (AXL)  receptor, which is a tyrosine kinase recep-
tor on the placental barrier cells while other Flaviviridae viruses cannot link with these recep-
tors [62]. The other important arboviruses that damage the nervous system include the Japanese 
encephalitis virus (JEV) from the family Flaviviridae [63]. The vector for JEV is Culex mosquito 
species that feeds mostly on birds and livestock blood while humans are the accidental host of 
the virus [63, 64]. JEV causes birth defects and certain neurological complications [63]. A number 
of vaccines are available, but it is still endemic in South East Asian countries [63, 65]. Beside its 
effects on nervous system, Zika virus also damages the kidneys, eyes and genital organs [66–69].
4. Current scientific progress
For understanding the pathobiology and development of vaccines and drugs, it is important 
to sequence the genome and crystallize the important proteins of Zika virus. Recently, a Zika 
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virus strain named ZikaSPH2015 genome has been fully sequenced that contained all the struc-
tural and nonstructural proteins. This strain was isolated from a patient in São Paulo, Brazil 
[70]. In the past, a Zika virus strain from French Polynesia was also sequenced and the results 
showed its Asian background [71]. It is important to compare the genome of different strains 
and observe the differences in them for the possible mutations. Previous phylogenetic studies 
showed that there are basically two strains, one Asian and the other African, with some modi-
fications due to glycosylation of amino acid sequence [72]. Recently, Kostyuchenko et al. have 
resolved a 3.7 Å resolution structure of Zika virus through cryoelectron microscopy [1], while 
Sirohi et al. have resolved a 3.8 Å resolution structure of mature particles [73]. As compared to 
other flaviviruses, Zika virus is stable even at 40°C. They also showed that its envelope (E) pro-
tein is similar in structure and function to that of West Nile and Japanese encephalitis viruses 
and dengue virus [1].
The isolation, purification and crystallization of different Zika virus proteins are also in prog-
ress and they will be helpful in designing vaccines and chemotherapeutic agents (Figure 1) 
[74]. The nonstructural protein (NS1) crystal structure showed unique electrostatic properties 
at the host interaction site and it is possible in different modes of action as compared to other 
NS1 proteins of flaviviruses [75]. It was also observed that the NS1 codons are helping more 
in adaptation to humans, as in the past Zika virus was more restricted to the zoonotic cycle 
[76]. Tian et al. resolved the crystal structure of helicase of Zika virus and they observed that 
Figure 1. Sketch of the 11 kb genome of ZIKV and its important proteins. (A) The polyprotein and its cleavage products. 
(B) Topology of the polyprotein inside the membrane [85].
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structurally it is similar to that of dengue virus but there are some differences in the motor 
domain [77]. That is why, Zika helicase binds to RNA differently  and certain conformational 
changes can be seen in the motor domain [77]. Jain et al. resolved a 1.6 Å resolution structure 
of nonstructural (NS3) protein that acts as an RNA helicase of Zika virus, which was a French 
Polynesia strain [78]. This NS3 has similarity with that of dengue NS3 but there are some 
variations in its binding loops of ATP and RNA. This NS3 structure might be helpful in mak-
ing necessary drugs to control Zika virus [78]. Rossi et al. studied Zika virus in murine models 
and this study could be helpful in the development of vaccines and drugs [79]. Shan et al. 
made an infectious cDNA clone of Zika virus using the clinical isolated strain of Zika virus 
of Asian origin [80]. This cDNA clone can infect the brain cells in mice and it can also infect 
the Aedes mosquito; thus, it is a useful tool to study the virus transmission, related diseases 
and research suitable therapeutics [80]. Like dengue virus, model studies suggested that there 
are chances that it will spread throughout the world [81, 82] and it may be possible to spread 
along with other flaviviruses like dengue, West Nile virus, chikungunya and Stratford virus 
due to the common vector Aedes [83, 84].
5. Vaccine and drugs
Some scientific groups have suggested releasing the Wolbachia-harboring mosquitoes in 
the environment as competitors for Aedes mosquitos because they are resistant and they 
do not carry Zika virus; in this way, we can control the spread of Zika virus [86]. There 
is no vaccine or medicine available for the treatment of Zika virus, so it is important to 
be safe from mosquito bite and sexual contacts in Zika virus–affected places, which is the 
only solution [34, 87]. The health departments of USA are giving guidelines from time to 
time for prevention and control of Zika virus [88, 89]. Currently, different research insti-
tutes are working in developing a vaccine against this virus, but it will certainly take time 
in preparing it [90–93]. It has been observed that the polyphenol epigallocatechin 3-gal-
late (EGCG) inhibits the entry of Zika virus into the cell [94]. This polyphenol is present 
in green tea and is also part of many dietary supplements. Such observations were also 
recorded previously for other viruses, especially hepatitis C and herpes simplex, but how 
efficient this compound exactly is and its mechanism of action are still not clear [95–99]. 
Larocca et al. made DNA vaccines that express the premembrane and envelope protein 
of Zika and offer protection against the Brazilian virus challenge in murine models [100]. 
This initial vaccine development is a positive sign of a more effective vaccine development 
and its marketing in the near future for the control of Zika virus. It is also reported that 
those parts of Brazil where yellow fever vaccination was done have lower level of micro-
cephaly cases due to Zika virus [101]. Thus, there is a possibility that the yellow fever vac-
cine may be helpful for the treatment of Zika virus infection. An opposite case to this was 
reported where a male American traveler had yellow fever vaccination record but still he 
developed symptoms of Zika virus infection like rash, fever, extreme fatigue, back pain 
and conjunctivitis [102]. There are also suggestions to develop better mouse and other ani-
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mal models that can be used to study the pathogenesis and vaccine development of Zika 
virus; further, the already present neuroteratogenic problem–causing virus models can 
also be utilized for Zika virus infection [103–106]. Computational studies predicted that 
the antibodies are produced in humans during Zika virus and the infection causes an auto-
immune response that results in rash, microcephaly and other symptoms [107]. Therefore, 
remedy for such autoimmune proteins should also be considered for treatment during 
development of vaccines and drugs. On the drug and development side, it was noted that 
the 7-deaza-2′-C-methyladenosine (7DMA) has the potency to inhibit the replication of 
Zika virus in mice, and further trials should be performed to check its efficiency against 
different strains of Zika virus [108]. Eyer et al. tested a series of substituted nucleoside 
bases to inhibit the replication of Zika virus and they observed that the 2′-C-methylated 
nucleosides are promising drug candidates [109]. For research purposes, it has been sug-
gested that the famous adenosine analog NITD008 that has been used in the past against 
other viruses [110–112] also has the antiviral activity both in vitro and in vivo against Zika 
virus [113]. Now, the sequences and in some cases the crystal structure of different impor-
tant Zika virus proteins are available and they can be targeted through computational 
drug designing techniques [114–117]. Similarly, the already available data on the closely 
related viruses like dengue virus enzymes can be exploited for novel drug design [118]. In 
mouse model, it was noted that 25-hydroxycholesterol prevents the entry of virus particles 
inside the cell and is the first line of defense molecule [119]. One of the positive aspects of 
ZIKV is that it can be utilized for brain cancer treatment. It was observed that the ZIKV 
possesses oncolytic properties and it can destroy brain cancer cells called glioblastoma 
with high specificity [120].
6. Conclusions
The way Zika virus is spreading silently first in South America and now in Asian countries is 
quite alarming. If the spread continues and microcephaly cases increase, then a whole gen-
eration born might be a patient of microcephaly. Zika virus has already affected the tourism 
economy of different countries, and if this spread persists in Asia, then the loss will be too 
large. There is a need to figure out how exactly Zika virus causes microcephaly. The current 
research progress in terms of vaccine and drug development is at a snail pace and collabora-
tive efforts are required to control this viral disease. Further, the spread of Aedes mosquitoes 
is also alarming as they are the source of other viruses too, and controlling the vector means 
control on ZIKV, dengue and chikungunya.
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